Company / Operating Income per Share
Cyclerion Therapeutics, Inc. Operating Income per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.95
FY2025
5-year range
-$8.52 / -$0.43
FY2021-FY2025
Trend
+62.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-8.52 to $-1.95 over the past 2 years.
Based on SEC 10-K filings.
-1.95 in FY2025.
Improved from $-8.52 to $-1.95 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 62.7% year-over-year.
- Peak operating income per share was recorded in FY2022.
- Lowest operating income per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -19.82 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.95 | +62.7% |
| FY2024 | -$5.23 | +38.6% |
| FY2023 | -$8.52 | -1895.0% |
| FY2022 | -$0.43 | +84.0% |
| FY2021 | -$2.67 | +41.0% |
| FY2020 | -$4.53 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026